O.TM Biotech's Chief Scientist and Larkin Hospital doctors have designed the Clinical Trials for Breast Cancer to ensure safety and efficacy. The Clinical Phrase I/II will be conducted to achieve the designed end-points.
The core of Larkin Health System's mission is to provide access to compassionate care of the highest quality in an educational environment. Larkins Health Systems subscribes to the Triple Aim of Care, Health and Cost: Continually researching ways to improve the experience of care, improving health of populations and reducing per capita costs of healthcare which is in sync with O.TM Biotech's mission of providing an advanced cancer therapeutic at a low cost.
About Larkin Health System
Larkin Health System is an integrated healthcare delivery system accredited by the Joint Commission with locations in South Miami, Hialeah and Hollywood, Florida. Their network of acute care hospitals provide a complete continuum of healthcare services, including a full range of inpatient and outpatient services. The Cancer Center at Larkin specializes in providing the latest advances in the treatment of cancer.
Dr. Azza Sarfraz MBBS Lead Principle Investigator for Clinical Trials
Dr. Sarfraz has formed a team to work with O.TM Biotech. Her team consists of 17 dedicated doctors also working in collaboration with Larkin Community Hospital. Together, the group of dedicated doctors are exploring and advancing cancer treatment through intense research, and focus. The aim is to advance cancer treatment through robust clinical trials.
Dr. Sarfraz is a research associate at the Aga Khan University Hospital, Karachi, Pakistan. She is appointed by the Division of Women and Child Health in the Department of Paediatric and Child Health with special focus on public health and translational medicine. Dr. Sarfraz is working as a graduate medical researcher at the Larkin Community Hospital, South Miami, Fl, USA.